Beata Ponikowska

Prof. Beata Ponikowska

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
EJEwa Jankowska
Ewa Jankowska
PRPiotr Rozentryt
Piotr Rozentryt
AWAgnieszka Witkowska
Agnieszka Witkowska
JNJolanta Nowak
Jolanta Nowak
OHOliver Hartmann
Oliver Hartmann
PPPiotr Ponikowski
Piotr Ponikowski

1 June 2009 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
EJEwa Jankowska
Ewa Jankowska
GFGerasimos Filippatos
Gerasimos Filippatos
BPBeata Ponikowska
Beata Ponikowska
LBLudmila Borodulin-Nadzieja
Ludmila Borodulin-Nadzieja
SAStefan D. Anker
Stefan D. Anker
PPPiotr Ponikowski
Piotr Ponikowski

1 January 2009 in European Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
EJEwa Jankowska
Ewa Jankowska
JJJustyna Jakubaszko
Justyna Jakubaszko
ACAldona Cwynar
Aldona Cwynar
JMJacek Majda
Jacek Majda
BPBeata Ponikowska
Beata Ponikowska
PPPiotr Ponikowski
Piotr Ponikowski
Aims Bone status has not been comprehensively studied in chronic heart failure (CHF). In CHF men, we evaluated bone status, bone loss over time, and their clinical and hormonal determinants. Methods and results Bone mineral content (BMC) and bone mineral density (BMD) of arms, legs, trunk, and total body were examined using dual‐energy X‐ray absorptiometry in 187 men with CHF [age: 60±11 years, left ventricular ejection fraction (LVEF): 32±7%, New York Heart Association (NYHA) class (I/II/III/IV): 20/76/76/15] and in 21 age‐matched male controls without CHF. Men with CHF had reduced BMD and BMC compared with controls (P < 0.05). Reduced BMD and BMC were independently determined by CHF severity (high NYHA class and impaired LVEF), reduced lean tissue mass, low serum dehydroepiandrosterone sulphate, total testosterone (TT), and estimated free testosterone (eFT) (all P < 0.05). Bone status was reassessed in 60 patients who survived >2 years from the initial evaluation. Significant bone loss over time (a reduction in BMC total ≥1%/year) occurred in 35% of CHF men. Advanced NYHA class (P < 0.05) and reduced serum TT and eFT (P < 0.0001) at baseline predicted augmented bone loss. Conclusion In CHF men, reduced BMD and BMC constitute an element of generalized body wasting, determined mainly by advanced heart failure and androgen deficiencies. Significant bone loss over time frequently occurs in CHF men and is related to testosterone depletion and disease severity.

1 February 2007 in International Journal of Cardiology
Verified
Journal Article
Closed access
EJEwa Jankowska
Ewa Jankowska
BPBeata Ponikowska
Beata Ponikowska
JMJacek Majda
Jacek Majda
RZRobert Zymliński
Robert Zymliński
MTMieczyslaw Trzaska
Mieczyslaw Trzaska
PPPiotr Ponikowski
Piotr Ponikowski

3 September 2010 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
BPBeata Ponikowska
Beata Ponikowska
EJEwa Jankowska
Ewa Jankowska
JMJolanta Maj
Jolanta Maj
KWKinga Wegrzynowska-Teodorczyk
Kinga Wegrzynowska-Teodorczyk
BBBartosz Biel
Bartosz Biel
PPPiotr Ponikowski
Piotr Ponikowski

16 November 2010 in Clinical Autonomic Research
Verified
Journal Article
Closed access
PDF file
ARAgnieszka Rydlewska
Agnieszka Rydlewska
EJEwa Jankowska
Ewa Jankowska
BPBeata Ponikowska
Beata Ponikowska
LBLudmiła Borodulin-Nadzieja
Ludmiła Borodulin-Nadzieja
WBWaldemar Banasiak
Waldemar Banasiak
PPPiotr Ponikowski
Piotr Ponikowski